Clinical Trial Update: Maintenance Dovitinib for Colorectal and Pancreas Cancer [Phase 2]

View source ↗

Summary

This Phase 2 maintenance study of dovitinib in colorectal cancer and pancreatic cancer was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• Dovitinib (dovitinib)

Snippet

Sponsor: Georgetown University | Conditions: Colorectal Cancer, Pancreas Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-07-19